Clinical Trials Browser

Skin Neoplasms × Interleukin-2 × 90 days × Clear all

NCT04562129 2026-04-01

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Phase 2 Recruiting

Melanoma, Skin Neoplasms